60 Degrees Pharmaceuticals, Inc. (SXTP)
0.4969
+0.03
(+6.72%)
USD |
NASDAQ |
Jan 16, 10:27
60 Degrees Pharmaceuticals Profit Margin (Quarterly): -438.1% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Processa Pharmaceuticals, Inc. | -- |
| CEL-SCI Corp. | -- |
| AIM ImmunoTech, Inc. | -12.63K% |
| IGC Pharma, Inc. | -953.4% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -193.2% |
| Return on Assets | -132.5% |
| Return on Invested Capital | -186.2% |
| Gross Profit Margin (Quarterly) | -1.72% |
| Operating Margin (Quarterly) | -439.9% |
| Return on Net Operating Assets | -568.5% |